Home » Electronics & Semiconductors » Report predicts burden of mental illness will cost $US16 trillion by 2030

Report predicts burden of mental illness will cost $US16 trillion by 2030

Ahead of this week?s first global mental health commission in London, the ?Lancet Commission? report has concluded current conditions in the way we deal with and prevent mental illness will cause lasting helm to the economy as well as communities at large around the world.

Contributing to the report are 28 global experts in the fields of psychiatry, public health, neuroscience, patients and advocacy groups. They conclude that ?no country is investing enough? factoring in the dramatic rise of mental illness in the past 25 years.

With mental illness on the rise each month in every country the report estimates this will have cost the global economy up to $US16 trillion (?14 trillion; $A23 trillion) in the 20 year period between 2010 and 2030 without adequate prevention or response.

The report factors in direct costs of health care, medicines and therapy, however, co-lead author Professor Vikram Patel notes most of the costs are indirect from the loss of productivity, education, spending on social welfare and law and order.

Speaking to reporters in the United States, Patel, a professor at Harvard Medical School states the situation is ?extremely bleak.?? He attributes the ?dramatic? rise in mental illness to ageing societies and that ?no country has invested enough? in the past 25 years.

According to the World Health Organisation (WHO), there are around 300 million people worldwide who suffer depression, 50 million with dementia, schizophrenia affecting 23 million and bipolar disorder affecting 60 million.

The report also draws issue with the gross human rights violations in many countries where people with mental disorders such as anxiety and schizophrenia are tortured or imprisoned. It concludes that a human-rights-based approach is needed, where people with mental health conditions are allowed access to employment and education.

Other recommendations include community-based care for mental health patients where talk-therapies can be more readily available through community health workers and teachers, for example.

neuroCare bietet spezialisierte und integrierte Behandlungen personalisiert für Patienten mit ADHD, Schlafstörungen, Depressionen und Zwangsstörung an. Bei der Behandlung dieser Krankheiten werden nur neueste und evidenz-basierte Therapien verwendet, die in einem klinisch-psychologischen Behandlungsansatz eingebettet sind. Personalisiertes Neurofeedback wird in der Behandlung der ADHD und die Hirnstimulation mittels rTMS für die Therapie der Depression angewandt. neuroCare betreibt ein globales Netzwerk von Behandlungszentren in den USA, den Niederlanden, in Deutschland und Australien.

Posted by on 27. October 2018. Filed under Electronics & Semiconductors. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

You must be logged in to post a comment Login


Recent Comments

    © 2023 So-Co-IT. All Rights Reserved. Log in - Copyright by LayerMedia

    Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de Bloggeramt.de